"en-US"> Are You Dense :: Exchanging 'Mammography' Screening with 'Breast Cancer' Screening: No Refunds or Returns for Advanced Disease

Exchanging 'Mammography' Screening with 'Breast Cancer' Screening: No Refunds or Returns for Advanced Disease

Originally Posted Dec 28th, 2017

huff pos small.jpg
Nancy M. Cappello, Ph.D. Founder & Director,
Are You Dense, Inc. &
Are You Dense Advocacy, Inc.
See Bio
As I say good-bye to another Christmas season and head to the mall and my local post office to exchange a gift with one that fits or is more apropos to my personal needs, I am reminded of my more than a decade-old desire to exchange the term ‘mammography’ screening with ‘breast cancer’ screening – after all we do not screen for mammography but screen for breast cancer. I want a breast cancer screening program that is personalized based on the unique risks and personal preferences of women who choose to participate in screening. Without a shift to a personalized breast cancer screening program, participation rates in mammography screening may further decline.
In the last decade, there is increasing news about the overdiagnosis of mammography screening and its harms compared to its benefits. This month another Headlinegreeted women across the globe about the overdiagnosis and ineffectiveness of mammography screening from a study published in the BMJ. The study analyzed the mammography screening program in the Netherlands from 1989 to 2012 which concluded that the Dutch program had little impact on the burden of reducing advanced disease suggesting a marginal effect on mortality. Additionally, the authors concluded that half of screening detected cancers represent overdiagnosis.
Radiologists and supporters of mammography screening are yet again tasked with counteracting the growing trend of studies in peer-reviewed journals touting the harms of mammography. Often criticizing the faulty analysis of the most recent study and fiercely questioning the elaborate claims of overdiagnosis, the cheerleaders of mammography screening defend the importance of its role in finding early cancers and at the same time acknowledging an insignificant rate of overdiagnosis.
Overdiagnosis is defined as the detection of tumors at screening that might never have progressed to become symptomatic or life-threatening in the absence of screening. The challenge that currently exists is that we cannot discriminate between which cancers are progressive and potentially deadly.
Since my advanced stage breast cancer diagnosis in 2004, after never missing my mammography screening, I have studied the research of mammography screening and its impact on mortality. Given my significant diagnosis and that my faithful mammography screening did not benefit me but caused me harm and still may cost me my life, I should be the least enamored advocate of mammography screening. However, the impact of early detection by screening mammography, although not perfect, is beneficial to many women with its impact to reduce mortality from breast cancer. Coincidentally, a 2015 study from the Netherlands found that even in light of new treatments, the size of the cancer and how far it spread remains vital to surviving the disease.
I am personally aware that mammography is not an equal opportunity technology for access to an early diagnosis for many women with dense breast tissue. When a woman’s cancer is not detected at an early stage, even after faithfully participating in mammography screening, there are no refunds or returns. The benefits of early detection by mammography have failed these women. They are left with the harms of a later stage diagnosis, aggressive treatment options, quality of life issues and a greater likelihood of dying from breast cancer. In our state advocacy efforts, we still encounter physician-trade organizations that are neutral or opposed to dense breast tissue reporting legislation with the goal of initiating dialogue with health care providers leading to personalized screening. I have worked with women across this country, who were harmed in the worst way by dying from breast cancer, not from overdiagnosis but from underdiagnosis.
It’s time for the breast health community to exchange the term ‘mammography’ screening with ‘breast cancer’ screening. While most women, unless they have a genetic mutation or are at high risk of the disease, would begin their personal screening program with a mammogram, women with dense breast tissue could alternate in-between years with a different screening tool which fits their personal breast health needs, giving them a greater likelihood of reducing advanced cancers.
Despite decades of mammography screening, breast cancer remains one of the major causes of cancer deaths in women. Research concludes that early detection by screening reduces mortality from breast cancer by detecting cancer early, leading to a decline in the rate at which women present with late-stage breast cancer when a refund or a return has expired.
Below is Gail Zeamer’s story of an advanced stage 3C diagnosis, despite never missing her annual mammogram. She tells why she is advocating for a Breast Density Reporting Law in Wisconsin. Like many women with dense breast tissue, invisible by mammogram for years, Gail’s opportunity for an early diagnosis is over - no exchanges, no returns.

Back to Blog

blog comments powered by Disqus

Please browse the website further to learn about dense breast tissue, use the available resources, read and share stories and consider making a donation to help expose this BEST-KEPT SECRET about the limitations of mammography alone to detect cancer in women with dense breast tissues.

Are You Dense, Inc. is a 501(c)(3) public charity. IRS Tax ID 26-3643216. All donations are tax-deductible as allowed by law.

  • Are You Dense? Fact #1:

    Breast density is one of the strongest predictors of the failure of mammography screening to detect cancer.

  • Are You Dense? Fact #2:

    Two-thirds of pre-menopausal women and 1/4 of post menopausal women have dense breast tissue. 

  • Are You Dense? Fact #3:

    Adding more sensitive tests to mammography significantly increase detection of invasive cancers that are small and node negative.

  • Are You Dense? Fact #4:

    American College of Radiology describes women with "Dense Breast Tissue" as having a higher than average risk of Breast Cancer.

  • Are You Dense? Fact #5:

    While a mammogram detects 98% of cancers in women with fatty breasts, it finds only 48% in women with the densest breasts.

  • Are You Dense? Fact #6:

    A woman at average risk and a woman at high risk have an EQUAL chance of having their cancer masked by mammogram.

  • Are You Dense? Fact #7:

    Women with dense breasts who had breast cancer have a four times higher risk of recurrence than women with less-dense breasts.

  • Are You Dense? Fact #8:

    A substantial proportion of Breast Cancer can be attributed to high breast density alone.

  • Are You Dense? Fact #9:

    Cancer turns up five times more often in women with extremely dense breasts than those with the most fatty tissue.

  • Are You Dense? Fact #10

    There are too many women who are unaware of their breast density, believe their “Happy Gram” when it reports no significant findings and are at risk of receiving a later stage cancer diagnosis.